COVID-19 Antibody Levels After Vaccines

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

June 9, 2021

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Vaccine Preventable Disease
Interventions
BIOLOGICAL

COVID-19 Vaccination

Receipt of full COVID-19 vaccination

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Environmental Protection Agency (EPA)

FED

lead

University of North Carolina, Chapel Hill

OTHER